(1R)-1-[6-(trifluoromethyl)(3-pyridyl)]ethylamine, 97%, 1g

Methyl 5-Bromo-2-trifluoromethylbenzoate, 95.0%, 1g

2-(4-Fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane>98.0%(GC)(T)5g

(R)-1-Boc-3-Isobutylpiperazine, 95.0%, 100mg

4-Bromobenzamidine Hydrochloride>98.0%(HPLC)(T)1g

(2E)-1-(1,4-diazepan-1-yl)-3-phenylprop-2-en-1-one, 95.0%, 1g

Methyl 3'-hydroxy-[1,1'-biphenyl]-4-carboxylate, 97+%, 5g

N-Acetyl-L-histidine Monohydrate, 97.00%, 1g

N,N-Bis(2-hydroxyethyl)-N-methyldodecan-1-aminium bromide, 95.0%, 50g

Methyl 5-methyl-4-oxo-3,4-dihydrothieno[2,3-d]-pyrimidine-6-carboxylate, 90.0%, 1g

2-(1-Cyclohexenyl)cyclohexanone>85.0%(GC)500mL

Pezzo di riduzione ROTILABO® in fluoroplastica, 24/29, 29/32, 1 Pezzo

tert-Butyl 2-(2-(2-(2-bromoethoxy)ethoxy)ethoxy)acetate, 95%, 250mg